Kawasaki disease with profound systemic vascular involvements: An insightful pediatric case

Naila Nadeem1, Muhammad Nadeem Ahmad1, Muhammad Haseeb Malik2

  • 1Department of Radiology The Aga Khan University Hospital Karachi Pakistan.

Clinical Case Reports
|September 3, 2024
PubMed

Insights

This case report details a rare instance of Kawasaki disease (KD) in an infant with extensive vascular involvement beyond coronary arteries. Early multidisciplinary management and treatment were crucial for patient stabilization and favorable outcomes.

Area of Science:

  • Pediatric Cardiology
  • Rheumatology
  • Vascular Medicine

Background:

  • Kawasaki disease (KD) is a multisystem inflammatory syndrome affecting small to medium vessels in young children.
  • Coronary artery aneurysms (CAAs) are the most significant complication of KD.
  • The spectrum of vascular involvement in KD can extend beyond coronary arteries.

Observation:

  • A 2-month-old infant presented with an extremely rare and extensive vascular involvement in Kawasaki disease.
  • Aneurysmal dilatations were observed in the internal carotid arteries, descending aorta, intercostal arteries, celiac artery, superior mesenteric artery, and renal arteries.
  • The infant also developed pseudomonas sepsis, posing additional management challenges.

Findings:

  • A multidisciplinary approach combined with early treatment using intravenous immunoglobulin (IVIG) and dexamethasone was effective.
  • Despite severe coronary dilation and sepsis, the patient was stabilized and discharged after 11 days.
  • This case highlights the importance of recognizing a broader spectrum of vascular involvement in KD.

Implications:

  • Early recognition and prompt management are critical for favorable outcomes in complex Kawasaki disease cases.
  • Multidisciplinary collaboration is essential for managing extensive vascular involvement and complications.
  • Long-term follow-up, further research into screening tools, and management strategies for multi-organ involvement are necessary.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...